Abstract:Enzyme catalysis generally includes multiple physical and chemical processes, such as the substrate transportion and binding to the active site, the chemical reaction in the protein confined environment, and the product release, where any chemical or nonchemical step is probably to dominate the activity of enzyme. In order to understand the enzymatic efficiency, the classical molecular dynamics (MM MD) and combined quantum and classical molecular dynamics (QM/MM MD) simulations, in combination with the umbrella sampling, have been used to explore mechanisms for the enzymatic catalysis and the substrate transportion in several biological systems, including the detoxification of the G-type nerve agent sarin by phosphotriesterase (PTE), the hydrolysis of uridine by the pyrimidine-specific nucleoside hydrolase Yeik (CU-NH), and the transportation of naphthalimide-polyamine compounds into the drug sites by the bovine serum albumin (BSA).Extensive QM/MM MD and MM MD simulations show that the wild-type PTE enzyme is capable of hydrolyzing sarin but with a low catalytic efficiency. Dissociation of the degraded product from the binuclear zinc center is predicted to be the rate-determining step with the free-energy barrier of 21.0 kcal/mol, and the multiple chemical steps are involved in the dissociation process. The P-F cleavage of the substrate sarin follows a two-step mechanism, in which the nucleophilic attack of the bridging hydroxide leads to the P-O-mu formation with the free-energy barrier of 9.8 kcal/mol, and the subsequent P-F cleavage and the proton transfer from the mu-OH to the residue Asp301 yields the degraded product with the free-energy span of 12.3 kcal/mol. The relatively strong hydrogen-bond interactions between the substrate uridine and key residues in the active site of CU-NH play an important role in the substrate specificity. The enzymatic N-glycosidic bond cleavage of uridine by CU-NH is the rate-limiting step with the free energy barrier of about 20 kcal/mol, and the substrate protonation less influences the activity of CU-NH, completely different from other nucleoside hydrolases. The combined random acceleration molecular dynamics and MD simulations (RAMD MD) have been used to explore possible transportation channels and the most favorable pathways for the delivery of the naphthalimide-polyamine complex to two drug sites of BSA, as well as their thermodynamic and dynamic properties. MM MD and RAMD MD simulations show that the selective specificity of these two drug sites strongly depends on the electron-withdrawing and electron-donating substituents of the substrate, which can be used for the design of new naphthalimide drugs. Such site-selectivity-dependence design strategy may open up an avenue in drug discovery.With the fast development of low-scaling QM methodologies and the application of artificial intelligence neural network approaches to theoretical and computational chemistry, it can be expected to reduce the computational costs of QM treatment and improve the efficiency of QM/MM, which makes the direct QM/MM study of larger and more complex systems become possible. In addition, the improvement and development of coarse-grained models can surmount the spatial and temporal limitation of multiscale calculations and simulations. Accordingly, global simulations of extremely large and complicated biosystems can be realized in the future, which may provide a theoretical basis for further expanding the application of enzyme engineering.

Insight into the metabolism rate of quinone analogues from molecular dynamics simulation and 3D-QSMR methods.

Emerging Metabolic Profiles of Sulfonamide Antibiotics by Cytochromes P450: A Computational-Experimental Synergy Study on Emerging Pollutants.

In Silico Simulation of Cytochrome P450-Mediated Metabolism of Aromatic Amines: A Case Study of N-Hydroxylation

Profiling the Interaction Mechanism of Quinoline/Quinazoline Derivatives As MCHR1 Antagonists: an in Silico Method

Metabolite Identification of Emerging Disinfection Byproduct Dibromo-Benzoquinone in Vivo and in Vitro: Multi-strategy Mass-Spectrometry Annotation and Toxicity Characterization

Three-dimensional quantitative structure–activity relationship study for analogues of TQXs using CoMFA and CoMSIA

Quantum Mechanics/Molecular Mechanics Modeling of Regioselectivity of Drug Metabolism in Cytochrome P450 2C9

Molecular Modelling Studies of 3,5-Dipyridyl-1,2,4-triazole Derivatives As Xanthine Oxidoreductase Inhibitors Using 3D-Qsar, Topomer Comfa, Molecular Docking and Molecular Dynamic Simulations

QSAR Study and Molecular Design of Quinonlone Carboxylic Acid Derivatives Based on Topomer CoMFA Method

An Adjusted 3D-QSAR Model for the Combined Activity of Fluoroquinolones Photodegradation and Microbial Degradation Assisted by Dynamic Simulation and Its Application in Molecular Modification.

A novel quantitative structure-activity relationship method to predict the affinities of MT3 melatonin binding site.

Mapping the Binding Site of a Large Set of Quinazoline Type EGF-R Inhibitors Using Molecular Field Analyses and Molecular Docking Studies.

The 3D-QSAR analysis of 4(3H)-quinazolinone derivatives with dithiocarbamate side chains on thymidylate synthase.

Qm/Mm Study Of The Enzymatic Catalysis

Study on the Activity of Non-Purine Xanthine Oxidase Inhibitor by 3D-Qsar Modeling and Molecular Docking

Integration of Fuzzy Matter-Element Method and 3D-QSAR Model for Generation of Environmentally Friendly Quinolone Derivatives

Three-dimensional Quantitative Structural-Activity Relationship and Molecular Dynamics Study of Multivariate Substituted 4-Oxyquinazoline HDAC6 Inhibitors

QSAR Analysis of Substituted Benzylamino- and Heterocyclylmethylamino-Carbodithioate Derivatives of 4-（3H）-quinazolinone Using CoMFA and SCORE2.0

Structural Requirements of 3-Carboxyl-4(1h)-quinolones As Potential Antimalarials from 2D and 3D QSAR Analysis

3D‐QSAR, Molecular Docking and Molecular Dynamics Analysis of 1,2,3,4‐tetrahydroquinoxalines As BRD4/BD2 Inhibitors

QSAR and molecular design of some quinoline derivatives as antimicrobial